Background Exercise is recommended for people with cancer. The aim of this study was to
evaluate the harms of exercise in patients with cancer undergoing systemic treatment …

The six-minute walk test (6MWT) is a widely used test for the indirect measurement of
cardiorespiratory fitness in various cancer populations. Although the 6MWT is a simple test …

The use of the adjuvant therapeutic antibody trastuzumab in breast cancer is associated with
a range of cardiotoxic side effects despite successfully reducing the severity of outcomes …

Cancer treatment–induced cardiotoxicities are an ongoing concern throughout the cancer
care continuum from treatment initiation to survivorship. Several “standard-of-care” primary …

Background Anthracyclines and monoclonal antibodies against human epidermal growth
factor receptor-2 (HER2) are frequently used to treat breast cancer but they are associated …

Breast cancer is the most frequent malignant neoplastic disease in women, with an
estimated 2.3 million cases in 2020 worldwide. Its treatment depends on characteristics of …

Purpose We aimed to assess the impact of aerobic exercise (AE) on parameters related to
cardiotoxicity in breast cancer (BC) patients receiving anthracycline or trastuzumab …

Breast cancer is the most common form of cancer in women and its incidence has been
increasing over the years. Human epidermal growth factor receptor 2 (HER2 or ErbB2) …

Background Despite advances in cancer treatment that have improved survival rates among
patients with breast cancer, they are at high risk of developing cancer therapy-related …

Background Effects of exercise in patients with breast cancer have been thoroughly
investigated. The aim was to explore differences in effects regarding type, delivery mode …